These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19548923)

  • 21. Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia.
    Ananda-Rajah MR; Charles PG; Melvani S; Burrell LL; Johnson PD; Grayson ML
    Scand J Infect Dis; 2008; 40(4):293-300. PubMed ID: 17918017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care.
    Holm A; Nexoe J; Bistrup LA; Pedersen SS; Obel N; Nielsen LP; Pedersen C
    Br J Gen Pract; 2007 Jul; 57(540):547-54. PubMed ID: 17727747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients.
    Menéndez R; Torres A; Rodríguez de Castro F; Zalacaín R; Aspa J; Martín Villasclaras JJ; Borderías L; Benítez Moya JM; Ruiz-Manzano J; Blanquer J; Pérez D; Puzo C; Sánchez-Gascón F; Gallardo J; Alvarez CJ; Molinos L;
    Clin Infect Dis; 2004 Dec; 39(12):1783-90. PubMed ID: 15578400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia.
    Arnold F; LaJoie A; Marrie T; Rossi P; Blasi F; Luna C; Fernandez P; Porras J; Weiss K; Feldman C; Rodríguez E; Levy G; Arteta F; Roig J; Rello J; Ramirez J;
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):739-43. PubMed ID: 16848334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation.
    Tejerina E; Frutos-Vivar F; Restrepo MI; Anzueto A; Palizas F; González M; Apezteguía C; Abroug F; Matamis D; Bugedo G; Esteban A;
    J Crit Care; 2005 Sep; 20(3):230-8. PubMed ID: 16253791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial.
    Snijders D; Schoorl M; Schoorl M; Bartels PC; van der Werf TS; Boersma WG
    Eur J Intern Med; 2012 Jul; 23(5):436-41. PubMed ID: 22726372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prediction model for community-acquired Chlamydia pneumoniae pneumonia in hospitalized patients.
    Socan M; Kosmelj K; Marinic-Fiser N; Vidmar L
    Infection; 2004 Aug; 32(4):204-9. PubMed ID: 15293075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia--influence of antibiotic pre-treatment: results from the German competence network CAPNETZ.
    Krüger S; Ewig S; Kunde J; Hanschmann A; Marre R; Suttorp N; Welte T;
    J Antimicrob Chemother; 2009 Jul; 64(1):159-62. PubMed ID: 19403654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia.
    Dwyer R; Hedlund J; Darenberg J; Henriques-Normark B; Naucler P; Runesdotter S; Kalin M
    Scand J Infect Dis; 2011 Jul; 43(6-7):448-55. PubMed ID: 21370939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-reactive protein levels and decrease of albumin levels in hospitalized elderly patients with community-acquired pneumonia.
    Harimurti K; Setiati S
    Acta Med Indones; 2007; 39(1):13-8. PubMed ID: 17297204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study.
    Renaud B; Coma E; Labarere J; Hayon J; Roy PM; Boureaux H; Moritz F; Cibien JF; Guérin T; Carré E; Lafontaine A; Bertrand MP; Santin A; Brun-Buisson C; Fine MJ; Roupie E;
    Clin Infect Dis; 2007 Jan; 44(1):41-9. PubMed ID: 17143813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: a meta-analysis of 1230 children.
    Flood RG; Badik J; Aronoff SC
    Pediatr Infect Dis J; 2008 Feb; 27(2):95-9. PubMed ID: 18174874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia.
    Phua J; See KC; Chan YH; Widjaja LS; Aung NW; Ngerng WJ; Lim TK
    Thorax; 2009 Jul; 64(7):598-603. PubMed ID: 19386583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of resolution of chest radiograph abnormalities in adults hospitalized with severe community-acquired pneumonia.
    Bruns AH; Oosterheert JJ; Prokop M; Lammers JW; Hak E; Hoepelman AI
    Clin Infect Dis; 2007 Oct; 45(8):983-91. PubMed ID: 17879912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia.
    Bruns AH; Oosterheert JJ; Hak E; Hoepelman AI
    Eur Respir J; 2008 Sep; 32(3):726-32. PubMed ID: 18508833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.
    Gallego M; Pomares X; Capilla S; Marcos MA; Suárez D; Monsó E; Montón C
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2633-2640. PubMed ID: 27799762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia.
    Esposito S; Bianchini S; Gambino M; Madini B; Di Pietro G; Umbrello G; Presicce ML; Ruggiero L; Terranova L; Principi N
    BMC Pulm Med; 2016 Jul; 16(1):103. PubMed ID: 27439403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of haemostasis and endothelial dysfunction characteristics in patient with community-acquired pneumonia].
    Bedilo NV; Vorob'eva NA; Ismaĭlova NV; Veshchagina NA; Nasonov IIa; Malugin IuIu
    Anesteziol Reanimatol; 2014; (1):33-8. PubMed ID: 24749306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of incorporating a pneumonia severity index into the admission protocol for community-acquired pneumonia.
    Jo S; Kim K; Jung K; Rhee JE; Cho IS; Lee CC; Singer AJ
    J Emerg Med; 2012 Feb; 42(2):133-8. PubMed ID: 20542398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of D-dimer in predicting mortality in patients with community-acquired pneumonia.
    Nastasijević Borovac D; Radjenović Petković T; Pejčić T; Stanković I; Janković I; Ćirić Z; Rančić M
    Med Glas (Zenica); 2014 Feb; 11(1):37-43. PubMed ID: 24496339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.